Antonio Ciaccia
banner
aciaccia.bsky.social
Antonio Ciaccia
@aciaccia.bsky.social
Advocate for drug price transparency, competitive healthcare markets, & patient-centered care at 46brooklyn Research and 3 Axis Advisors. Dad to Franco, Marco, Vera, Enzo.
“That sounds criminal.”

Great chatting by with Paul Miller at WPHM about bloated prescription drug prices and how our reliance on conflicted intermediaries to control them can often make affordability issues even worse www.wphm.net/episode/nove...
November 26 Antonio Ciaccia
Rising prescription drug prices
www.wphm.net
November 28, 2025 at 8:04 PM
The waves of community pharmacy closures keep coming; this time it’s my good friends over at Fruth Pharmacy.

More neighborhoods of need in Ohio and West Virginia turning into pharmacy deserts.

Another reminder that you get what you pay for. wchstv.com/news/local/f...
Fruth to sell its pharmacies to Walgreens by the end of the year
A pharmacy chain that has served the region for decades has announced it is selling its practices.Fruth Pharmacy announced this week that it will sell its pharm
wchstv.com
November 20, 2025 at 8:46 PM
I will give you an 80% discount off the price of your cup of coffee.

Sounds great, right?

Let's sign a contract where all your coffee purchases go through me, and I will honor that 80% discount every time.

BTW, I also set the price of that coffee.
This drug pricing distortion was supposed to go extinct. It’s never been more alive. — 46brooklyn Research
This summer, we launched a new research work that examined the costs yielded by a reborn and evolved species of the prescription drug supply chain: drug companies who are also part of larger vertica...
www.46brooklyn.com
November 11, 2025 at 3:03 PM
PBMs say they want low list prices for drugs.

Their new affiliated private label drug companies now have the power to do it themselves.

Instead, the generic prices are on average 33 times higher than the lowest in the market.

www.bloomberg.com/news/article...
Cigna Unit Sells Generic Drugs at Higher Prices, Report Says
A little-known Cigna Group subsidiary that sells generic drugs charges prices that skew higher than many competing suppliers, according to a new analysis that raises questions about the company’s role...
www.bloomberg.com
November 7, 2025 at 4:22 PM
“Soaking high drug prices as a mechanism to lower premiums is neither a wise nor a sustainable practice.”

Acknowledge @repauchincloss.bsky.social 🎙️

www.realpharma.co/where-policy...
Where Policy Meets the Pharmacy Counter
Where Policy Meets the Pharmacy Counter Featuring Congressman Jake Auchincloss Episode Summary In this episode of RealPharma , hosts Na-Ri Oh and Ian Wendt sit down…
www.realpharma.co
October 13, 2025 at 5:13 PM
When Amazon makes moves in pharmacy – no matter how seemingly small – you should always be thinking about the long game @nyeungs.bsky.social

endpoints.news/whats-behind...
What's behind Amazon’s in-person pharmacy play
Amazon to install prescription medication dispensing machines at One Medical clinics, starting in Los Angeles this December, marking its first in-person pharmacy presence.
endpoints.news
October 9, 2025 at 6:24 PM
Good news for fans of generic drug affordability 👇

www.wsj.com/health/pharm...
Exclusive | Trump Excludes Generics From Big Pharma Tariff Plan
The administration has been weighing duties for months on a range of products and ingredients in a national-security tariff investigation.
www.wsj.com
October 9, 2025 at 1:19 PM
“American businesses should not be left to subsidize the lack of transparency, accountability and fair competition in the health care industry.”

www.washingtontimes.com/news/2025/oc...
Congress must address the health care cost crisis now
Our health care system has a pressing need for greater competition and transparency.
www.washingtontimes.com
October 8, 2025 at 11:04 PM
The price is the price.

Unless it’s the other price.

Generic drug prices are going up and down – depending on your perspective.

www.46brooklyn.com/research/are...
Are generic drug prices going up or down? Depends on which benchmark you ask — 46brooklyn Research
For the first time: Year-over-year generic drug price inflation For those unfamiliar, our team at 46brooklyn Research have a thing for tracking prescription drug prices. Not just the prices of d...
www.46brooklyn.com
October 2, 2025 at 1:29 PM
“The immediate stock reaction across the group affirms our view this is more optics than bite.”

Good rundown on yesterday’s Trump/Pfizer rendezvous from @elaineywchen.bsky.social

www.statnews.com/2025/09/30/w...
Will the White House drug-pricing deal lower costs for Americans? Experts are skeptical
Will the White House drug-pricing deal lower costs for Americans? Experts are skeptical.
www.statnews.com
October 1, 2025 at 10:36 PM
If you are someone who wants more drug manufacturing in the U.S., this may please you.

If you are someone who wants lower brand drug prices in the U.S., this may tariffy you.

www.usatoday.com/story/money/...
Trump announced new drug tariffs. How much will you pay at the pharmacy counter?
President Donald Trump announced 100% tariffs on brand drugs. Companies that build a U.S. manufacturing plant will be exempt.
www.usatoday.com
September 26, 2025 at 6:15 PM
Yeah, that’ll fix it.

www.bloomberg.com/news/article...
September 25, 2025 at 2:52 PM
There are 281 brand-name drugs with new list prices.

Here are the details.
A quarterly-ish review of U.S. drug price changes — 46brooklyn Research
As a non-profit, we at 46brooklyn have made it our goal to provide insights into U.S. drug pricing data available in the public domain based upon the figures we are able to get our nerdy hands on. Whi...
www.46brooklyn.com
September 22, 2025 at 9:21 PM
Another state attorney general digs into drug pricing bloat and dysfunction 👇

www.oag.state.va.us/media-center...
September 13, 2025 at 1:15 PM
As a long-time fan of his show, it was awesome to join Clay Farris for a discussion about American drug pricing dysfunction.

mostlymedicaid.com/medicaid-con...
September 9, 2025 at 1:14 AM
“The current system is riddled with barriers to innovation, shielded by exclusivity protections and mired in anticompetitive practices — which help ensure high drug prices persist.”

@blueshieldca.bsky.social www.healthcaredive.com/news/drug-in...
Drug innovation should benefit patients. PBMs are preventing that from happening.
Health plans should directly contract with drug manufacturers to provide medications at transparent and affordable prices, argues Kathy Chang, head of trade relations at Blue Shield of California.
www.healthcaredive.com
August 23, 2025 at 5:08 PM
Reposted by Antonio Ciaccia
Potential positives and negatives aside, pharm-to-table is a band-aid on a mortal wound. @aciaccia.bsky.social www.ajmc.com/view/direct-...
Direct-to-Patient Apixaban Program Aims to Expand Access, Lower Out-of-Pocket Costs
Apixaban would still cost patients 9 times more through the Eliquis 360 Support program than with commercial insurance.
www.ajmc.com
August 17, 2025 at 11:49 AM
Behold the power of whistleblowers: $289.9 million set to come back to US government and certified G, Sarah Behnke
CVS unit must pay $290 million in drug whistleblower lawsuit, judge rules
A federal judge ordered CVS Health's pharmacy benefit manager unit to pay $289.9 million in damages and penalties after it overcharged Medicare for prescription drugs.
www.reuters.com
August 20, 2025 at 6:02 PM
The policy ground is shifting on the 340B program, which means the system's current winners and losers have their eyes on how proposed changes could impact their financial realities
340B rebate pilot tees up healthcare industry firestorm
Drugmakers want to convert 340B discounts to rebates under a federal pilot program set to launch in January. Providers are anxious.
www.modernhealthcare.com
August 18, 2025 at 9:37 PM